Patents Assigned to Agilent Technology, Inc.
-
Patent number: 12006937Abstract: A discharge muffler for a fluid pump is formed by a cowling and a muffler insert configured to be removably inserted into a muffler receptacle of the cowling. The muffler insert includes a muffler inlet, a muffler outlet, and a plurality of muffler walls. The pump includes a pumping stage, a motor, and a drive shaft coupled between the pumping stage and the motor. When the muffler insert is inserted into the muffler receptacle, the muffler inlet communicates with the pumping stage, and the cowling and the muffler insert cooperatively define the discharge muffler. The discharge muffler is configured or effective to suppress noise generated by fluid discharged from the pumping stage.Type: GrantFiled: June 7, 2022Date of Patent: June 11, 2024Assignee: Agilent Technologies, Inc.Inventors: Vannie Lu, George Galica
-
Patent number: 12006519Abstract: Mutant polymerases are provided that have improved ability to incorporate modified nucleotides, including 3?-OH unblocked reversible terminators. The mutant polymerases may be used in a variety of applications, such as for polynucleotide sequencing, primer extension reactions, and template-independent enzymatic oligonucleotide synthesis.Type: GrantFiled: September 11, 2023Date of Patent: June 11, 2024Assignee: Agilent Technologies, Inc.Inventors: Michelle Cayouette, Jeffrey Fox, Connie Hansen, Holly Hogrefe, Weidong Wu
-
Patent number: 12000808Abstract: A fluid supply device for providing a mobile phase for a sample separating device includes, a supply conduit for providing a fluid which forms at least a part of the mobile phase, a fluid valve which is fluidically coupled with the supply conduit and, depending on its switching state, enables or prevents a passing of the fluid from the supply conduit, an elastic buffer unit which is fluidically coupled upstream of the fluid valve with the supply conduit and which is configured for buffering the fluid, and a fluid conveying unit for conveying the fluid which passes the fluid valve.Type: GrantFiled: June 15, 2021Date of Patent: June 4, 2024Assignee: Agilent Technologies, Inc.Inventors: Clemens Plachetka, Konstantin Shoykhet, Tony Ziegler, Joachim-Richard Wagner, Manfred Berndt
-
Patent number: 12000810Abstract: A fitting assembly (100) is provided. The fitting assembly (100) comprises a holder (102) that holds one or more fluidic seal assemblies. The fluidic seal assembly comprises a fitting (104), a ferrule (110) and a tube (112), such as a chromatography column, and optionally comprises a protrusion (118) and a compliant seal material (120). Fluidic connections for a gas chromatography instrument are also provided.Type: GrantFiled: November 14, 2018Date of Patent: June 4, 2024Assignee: Agilent Technologies, Inc.Inventors: Richard P. White, Wesley M. Norman, Li Xu, Wen-Yi Ge
-
Patent number: 12003904Abstract: Systems and methods are disclosed for capturing and interpreting data streams between an instrument and a controlling device. A processor is configured to receive a data stream sent by the instrument to the controlling device and identify data frames in the stream. The processor is configured to search for a bit pattern in the stream, identify bits corresponding to a message length of a first presumed data frame based on a location relative to the bit pattern, and identify a second presumed data frame in the data stream based on the message length of the first presumed data frame. The processor is further configured to identify a second instance of the bit pattern, increase a count, continue scanning, extract and store instrument measurement data or operational metadata from the identified data frames, and analyze or interpret the captured data and metadata for visualization or alerts.Type: GrantFiled: June 30, 2021Date of Patent: June 4, 2024Assignee: Agilent Technologies, Inc.Inventor: Rick Fasani
-
Patent number: 11992518Abstract: The present invention relates to methods for construction of pharmamers i.e. vaccine components characterized by their multimerization domain and the attached biologically active molecules, and their use in preparation of vaccines that contains the pharmamers alone or in combination with other molecules. The individual molecules of the construct can be bound to each other or the multimerization domain(s) by covalent or non-covalent bonds, directly or via linkers. The invention further relates to the use of such preparations in vaccine settings aimed to function as preventive/prophylactic or therapeutic vaccines in humans and animals.Type: GrantFiled: June 27, 2019Date of Patent: May 28, 2024Assignee: Agilent Technologies, Inc.Inventors: Jørgen Schøller, Henrik Pedersen, Liselotte Brix
-
Patent number: 11993810Abstract: Chromogenic conjugates for color-based detection of targets are described. The conjugates comprise a chromogenic moiety such as a rhodamine, rhodol or fluorescein. The chromogenic moiety is linked to a peroxidase substrate. The chromogenic conjugates can be used in immunohistochemical analysis and in situ hybridization. The conjugates can be used to detect 1, 2, 3 or more targets in a sample by color.Type: GrantFiled: August 10, 2022Date of Patent: May 28, 2024Assignee: Agilent Technologies, Inc.Inventors: Jesper Lohse, Mike Paw Maischnack Hansen
-
Patent number: 11988633Abstract: The present disclosure provides methods of improving the resolution of labeled glycans in capillary electrophoresis techniques using a gel as a sieving matrix, by incorporating polyamines in the gel.Type: GrantFiled: September 20, 2018Date of Patent: May 21, 2024Assignee: Agilent Technologies, Inc.Inventors: Fielito U. Limjap, Michael J. Kimzey, Francis T. Haxo
-
Patent number: 11982606Abstract: Paraffin-embedded tissue, which may be disposed on a solid substrate, is prepared by a dry technique that removes paraffin from tissue without adding any liquid to the tissue, thereby rendering the tissue substantially free of paraffin. The dry technique may entail applying heat energy to the tissue effective to melt the paraffin and thereby render it flowable, and applying an electric field. The electric field is effective to impart electrical charge to the paraffin and to move the paraffin out from the tissue due to electrical charge repulsion or attraction, which may be assisted by moving an electrode utilized to generate the electric field relative to the paraffin. The electric field, or both the electric field and the heat energy, may be applied until the tissue is substantially free of paraffin.Type: GrantFiled: February 27, 2020Date of Patent: May 14, 2024Assignee: Agilent Technologies, Inc.Inventors: Victor Lim, Carol T. Schembri, Adrienne Mccampbell, Nazumi Alice Yama-Dang
-
Publication number: 20240118252Abstract: In a method of allocating a plurality of functional tasks to a plurality of functional devices each capable of carrying out one or more of the functional tasks, the functional devices are analytical devices and each of the functional tasks corresponds to a respective predefined process related to analyzing a respective sample by a respective one of the functional devices. The functional tasks are allocated to the functional devices based on a criterion to achieve compliance with at least one predefined control target of controlling the functional devices.Type: ApplicationFiled: October 9, 2023Publication date: April 11, 2024Applicant: Agilent Technologies, Inc.Inventors: Kyle Robert Busch, Stefan Mittrich, Udo Herynek
-
Patent number: 11946913Abstract: An injector is configured for injecting a fluidic sample from an injector path into a mobile phase in a separation path between a fluid drive and a sample separation unit of a sample separation device. The injector includes a control unit configured for generating a first overpressure in a blocked first partial path of the injector path by a first pressure source, for generating a second overpressure in a blocked second partial path of the injector path by a second pressure source, for subsequently fluidically coupling the first partial path with the second partial path for generating an expansion stroke for releasing a gas bubble in the injector path, and for rinsing the released gas bubble from the injector path.Type: GrantFiled: April 27, 2022Date of Patent: April 2, 2024Assignee: Agilent Technologies, Inc.Inventors: Thomas Ortmann, Martin Seifried, Sam Wouters, Irina Spuling
-
Patent number: 11940359Abstract: The present disclosure is directed to an improved method for distinguishing tissue from an embedding medium, such as paraffin in a formalin-fixed paraffin-embedded sample. The method involves the use of fluorescence of naturally-occurring species in tissue to determine the location of the tissue in the embedded sample. An embedded sample is generally excited by light of a selected wavelength, and the fluorescence emission at an emitted wavelength is used to locate the boundary or location of the tissue in the embedded sample.Type: GrantFiled: December 29, 2021Date of Patent: March 26, 2024Assignee: Agilent Technologies, Inc.Inventors: Kyle Schleifer, Kristin Briana Bernick, Adrienne Mccampbell, Nicholas M. Sampas, Victor Lim
-
Patent number: 11940442Abstract: The current technology is related to methods for rapidly determining the metabolic baseline and potential of living cells. Embodiments relate to measuring the activity of each of the two major energy-generating pathways within the cell: mitochondrial respiration and glycolysis, first under baseline conditions, and again after applying a stress to the cells to demand increased energy supply. In some embodiments the stress may be applied by exposing the cells to a combination of two chemical compounds: a mitochondrial uncoupler and an ATP synthase inhibitor. In one embodiment, the metabolic energy generating activity of the mitochondrial respiration pathway is determined by measuring the rate of oxygen consumption by the living cells, and the metabolic energy generating activity of the glycolysis pathway is determined from a measurement of extracellular acidification caused by secretion of protons from the cell.Type: GrantFiled: June 30, 2020Date of Patent: March 26, 2024Assignee: Agilent Technologies, Inc.Inventors: David A. Ferrick, Brian Dranka
-
Patent number: 11933769Abstract: A multidimensional sample separation apparatus includes a first separation dimension for separating a fluidic sample, a second separation dimension for further separating the fluidic sample, a switching mechanism, and a control unit. The first separation dimension includes a first fluid drive unit and a first sample separation unit. The second separation dimension includes a second fluid drive unit for driving the separated fluidic sample, and second and third sample separation units each configured for further separating the separated fluidic sample. The switching mechanism is configured for selectively switching an outlet of the first separation dimension in fluid communication with a selected one of the second sample separation unit and/or the third sample separation unit. The control unit is configured for controlling a pressure at inlets of the second sample separation unit and the third sample separation unit to be substantially the same at least at the time of the switching.Type: GrantFiled: April 30, 2019Date of Patent: March 19, 2024Assignee: Agilent Technologies, Inc.Inventors: Dwight Robert Stoll, Klaus Witt, Konstantin Shoykhet
-
Patent number: 11931918Abstract: A microfluidic component for a sample separation apparatus includes a component body including ceramic and at least one microfluidic structure in the component body. The component body is manufactured by additive manufacturing, in particular by three-dimensional printing.Type: GrantFiled: November 19, 2018Date of Patent: March 19, 2024Assignee: Agilent Technologies, Inc.Inventors: Darijo Zeko, Tony Ziegler, Thomas Ortmann
-
Patent number: 11926870Abstract: The present invention relates to the technical field of nucleic acid amplification using a Polymerase Chain Reaction (PCR). Specifically, the present invention relates to Polymerase Chain Reaction (PCR) primers and Polymerase Chain Reaction (PCR) nucleic acid amplification mixture and the use thereof in (quantitative) Polymerase Chain Reactions (PCR).Type: GrantFiled: February 10, 2021Date of Patent: March 12, 2024Assignee: Agilent Technologies, Inc.Inventor: Jurgen Del Favero
-
Patent number: 11921093Abstract: A mounting device for mounting a sample separation unit configured for separating, preferably chromatographically separating, compounds in a fluidic sample includes a first fluid connector configured for being mechanically and fluidically coupled with a first fluid interface of the sample separation unit, a second fluid connector configured for being mechanically and fluidically coupled with a second fluid interface of the sample separation unit, and a swivel mechanism configured for swivelling the first fluid connector between a mounting orientation for mounting the first fluid interface of the sample separation unit at the first fluid connector and an alignment orientation for aligning the second fluid interface of the mounted sample separation unit with the second fluid connector for subsequently coupling the second fluid interface with the second fluid connector.Type: GrantFiled: January 25, 2022Date of Patent: March 5, 2024Assignee: Agilent Technologies, Inc.Inventors: Daniela Loraing, Lena Höninger, Uwe Effelsberg, Andreas Otto, Ansgar Waldbaur, Armin Steinke, Thomas Ortmann, Michael Lang
-
Publication number: 20240058813Abstract: A fluid delivery device is configured to create a pressure differential across a compartment in which a liquid resides, causing the liquid to flow through the compartment. After a period of time, the fluid delivery device is configured to eliminate the pressure differential and thereby equilibrate the pressure across the compartment, with the use of a pressure equilibration channel that is separate from the compartment. The compartment may contain a packed bed of solid phase particles such as beads. In such case, the pressure differential causes the liquid to flow through the packed bed. The liquid may include chemical reagents or precursors that participate in chemical reactions on or at the solid phase particles. The reactions may relate to chemical synthesis, for example the synthesis of bio-chemicals such as nucleotides.Type: ApplicationFiled: August 19, 2022Publication date: February 22, 2024Applicants: Agilent Technologies, Inc., Agilent Technologies, Inc.Inventors: Jonathan Irribarren, Joel Myerson, Bo Curry
-
Patent number: 11884915Abstract: Provided herein are compositions and methods for inducing CRISPR/Cas-based editing of a target nucleic acid (e.g., target DNA or target RNA) in vitro or in a cell, using modified prime editing guide RNAs (pegRNAs) that incorporate one or more chemically-modified nucleotides. The modified pegRNAs disclosed herein may be used to induce Cas-mediated incorporation of one or more nucleotide changes and/or targeted mutagenesis of a target nucleic acid. The nucleotide change can include, e.g., one or more nucleotide changes, an insertion of one or more nucleotides, or a deletion of one or more nucleotides.Type: GrantFiled: September 12, 2022Date of Patent: January 30, 2024Assignee: Agilent Technologies, Inc.Inventors: Daniel E. Ryan, Robert Kaiser, Douglas J. Dellinger
-
Patent number: D1021136Type: GrantFiled: December 14, 2021Date of Patent: April 2, 2024Assignee: Agilent Technologies, Inc.Inventors: Jason Dell'Arciprete, Jon Arsenault